{"contentid": 488664, "importid": NaN, "name": "Executive moves at Merck\u00e2\u0080\u0099s Healthcare business sector", "introduction": "German pharma and life sciences firm Merck KGaA today announced changes in its operating model for its Healthcare business sector.", "content": "<p>German pharma and life sciences firm Merck KGaA (MRK: DE) today announced changes in its operating model for its Healthcare business sector.</p>\n<p>&ldquo;Our redesigned Healthcare organization creates dedicated leadership for our strategic priorities with a focus on growth,&rdquo; said Peter Guenter, a member of the executive board of Merck, and chief executive Healthcare. &ldquo;Our clear intent is to bring meaningful value to more patients with our current and future portfolio,&rdquo; he noted.</p>\n<p>Given the priority of North America as a driver of future growth for Merck&rsquo;s Healthcare business sector, dedicated leadership in this key market is essential. To this end, Chris Round will assume the role of president of EMD Serono, leading the US and Canada Healthcare business. Mr Round has been with the organization since 2017, previously serving as head of international and core franchises, and head of EMEA.</p>\n<p>Mr Round brings 25 years of global pharmaceutical experience to this position, including 20 years at MSD, the non-US and Canada trading name for Merck &amp; Co (NYSE: MRK). He will be based in Rockland, Massachusetts, USA.</p>\n<p>The ongoing launches of Bavencio (avelumab), Mavenclad (cladribine) tablets and Tepmetko (tepotinib) are critical elements of the business sector&rsquo;s growth strategy, Merck pointed out.</p>\n<p>Global launch excellence for existing and future therapies will be led by Andrew Paterson, who will assume the role of chief marketing officer for Healthcare. Mr Paterson will lead Merck&rsquo;s speciality franchises including oncology, neurology and immunology and fertility. In addition, he will lead global market access and pricing and global strategic insights.</p>\n<p>Mr Paterson brings nearly 30 years of leadership experience in the biopharmaceutical industry to this appointment. He previously led both North America and the global innovative medicine franchises. Mr Paterson will also be based in Rockland.</p>\n<p>The executive role, head of China &amp; International, will lead China and Japan as well as the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, and the franchise of cardiovascular metabolism and endocrinology (CM&amp;E). Recruitment for this position is ongoing.</p>", "date": "2021-05-18 16:30:00", "meta_title": "Executive moves at Merck\u00e2\u0080\u0099s Healthcare business sector", "meta_keywords": "Merck KGaA, Healthcare, Appointments, EMD Serono, Chris Round, Andrew Paterson, Chief marketing officer, Bavencio, Mavenclad. Tepmetko", "meta_description": "Executive moves at Merck\u00e2\u0080\u0099s Healthcare business sector", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-18 16:29:45", "updated": "2021-05-18 16:39:20", "access": NaN, "url": "https://www.thepharmaletter.com/article/executive-moves-at-merck-s-healthcare-business-sector", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "merck_kgaa_new_large.jpg", "image2id": "merck_kgaa_new_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Immunologicals, Neurological, Oncology, Reproductive", "topic_tag": "Boardroom, Management", "geography_tag": "Canada, Germany, USA", "company_tag": "EMD Serono, Merck KGaA", "drug_tag": "Bavencio, Mavenclad, Tepmetko", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-18 16:30:00"}